Skip to content

Insider · CIK 0001923217

Rachel Vaknin

cfoofficer

Files at MBOT (Microbot Medical Inc.). First filing -, latest -.

Rachel Vaknin files SEC Form 4 as CFO at MBOT (Microbot Medical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Rachel Vaknin has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 18, 2026MBOT
Microbot Medical Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+105,000$0.00$0105,000Feb 20, 2026

Questions about Rachel Vaknin

Answered from the filings on this page, as of the latest one.

Is Rachel Vaknin buying or selling?

Rachel Vaknin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Rachel Vaknin's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rachel Vaknin has 0.

Where does Rachel Vaknin file Form 4?

Rachel Vaknin has filed Form 4 at MBOT (Microbot Medical Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rachel Vaknin: insider trades and track record | InsiderTell